In silico cancer potential of 2-pyrrolidinones from marine origin

2-pyrrolidinones present a great variability of biological activities, particularly those of marine origin have given rise to a great diversity of these, so from them, through studies of structural similarity, molecular docking and ADMETx analysis, the potential carcinogenic activity of a library of 33 2-pyrrolidines from various marine organisms was found. Derived from this study, several compounds, such as Cephalimysins M, Cephalimysins N, Amycolactam and Spongialactam A, were shown to be excellent candidates against cancer, via JAK2, JAK3, PDE10A, MAPK14, PDE4A, PDE4B and EGFR, functioning at a mono or multi-target level, without negatively affecting the central nervous system and with low possible toxic effects.

Authors

Publication Details

Journal
GSC Biological and Pharmaceutical Sciences
Published
2025-03-09
DOI
https://doi.org/10.30574/gscbps.2025.30.3.0093
Primary Topic
Synthesis and Biological Activity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In silico cancer potential of 2-pyrrolidinones from marine origin

David M. Aparicio, Joel L. Terán, Alan Carrasco‐Carballo, Antonio Rosales-López et al.
GSC Biological and Pharmaceutical Sciences
Synthesis and Biological Activity
article

In silico cancer potential of 2-pyrrolidinones from marine origin

David M. Aparicio, Joel L. Terán, Alan Carrasco‐Carballo, Antonio Rosales-López, Victoria Rodriguez-Tzompantzi
article en

Abstract

2-pyrrolidinones present a great variability of biological activities, particularly those of marine origin have given rise to a great diversity of these, so from them, through studies of structural similarity, molecular docking and ADMETx analysis, the potential carcinogenic activity of a library of 33 2-pyrrolidines from various marine organisms was found. Derived from this study, several compounds, such as Cephalimysins M, Cephalimysins N, Amycolactam and Spongialactam A, were shown to be excellent candidates against cancer, via JAK2, JAK3, PDE10A, MAPK14, PDE4A, PDE4B and EGFR, functioning at a mono or multi-target level, without negatively affecting the central nervous system and with low possible toxic effects.

GSC Biological and Pharmaceutical SciencesVol. 30(3)
Openalex Percentile: Top 95%
Synthesis and Biological Activity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.